Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin.
To ascertain whether epithelial cells of oral cavity origin may be infected with human immunodeficiency virus (HIV-1), a study to determine susceptibility to infection of salivary gland epithelial cell lines (HSY and HSG) was undertaken. Because of the potential for oral-genital transmission, an endometrial cell line, HEC-1, was also studied. Epithelial cell monolayers were infected with cell-free HTLVIIIB or a primary HIV-1 isolate. Several lines of evidence indicated that inoculation of these cell lines with HIV-1 led to productive infection: 1) p24 antigen was present in supernatants, with levels peaking on days 3-4; 2) provirus was found in cells by polymerase chain reaction; 3) virions present in supernatants were infectious as confirmed by coculture with the T-lymphoblastoid line CEM-NKr. Following a period of virus production, HIV-1 entered a latency phase over 10 weeks. All epithelial cell lines were positive for galactosylceramide (GalC) and CXCR4. HSY was weakly positive for surface CD4, and also expressed mRNA for CD4 and CCR5, as did HEC-1. Blocking studies indicated that anti-GalC, but not anti-CD4, significantly reduced productive infection, and that regulated on activation normal T cell expressed and secreted (RANTES) but not stromal cell-derived factor (SDF-1) could partially block infection of the M-tropic primary isolate. These results suggest that epithelial cells in the oral cavity and the genital tract might be targets of HIV-1 and potentially serve as a mediator of systemic infection.
Han
Y
Y
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294-2170, USA.
Ventura
C L
CL
Black
K P
KP
Cummins
J E
JE
Hall
S D
SD
Jackson
S
S
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D018920:Coculture Techniques; D004717:Endometrium; D004847:Epithelial Cells / Q000821:virology*; D005260:Female; D005699:Galactosylceramides / Q000032:analysis / Q000378:metabolism; D016655:HIV Core Protein p24 / Q000032:analysis; D015497:HIV-1 / Q000254:growth & development* / Q000276:immunology; D006801:Humans; D011533:Proviruses / Q000302:isolation & purification*; D012333:RNA, Messenger / Q000032:analysis; D019713:Receptors, CCR5 / Q000032:analysis; D019718:Receptors, CXCR4 / Q000032:analysis; D012469:Salivary Glands; D013601:T-Lymphocytes / Q000821:virology; D013997:Time Factors; D017735:Virus Latency; D014779:Virus Replication
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D005699:Galactosylceramides; D016655:HIV Core Protein p24; D012333:RNA, Messenger; D019713:Receptors, CCR5; D019718:Receptors, CXCR4